France Nebulizer Market Size & Outlook, 2023-2030

The nebulizer market in France is expected to reach a projected revenue of US$ 90.6 million by 2030. A compound annual growth rate of 6.5% is expected of France nebulizer market from 2024 to 2030.
Revenue, 2023 (US$M)
$58.1
Forecast, 2030 (US$M)
$90.6
CAGR, 2024 - 2030
6.6%
Report Coverage
France

France nebulizer market highlights

  • The France nebulizer market generated a revenue of USD 58.1 million in 2023 and is expected to reach USD 90.6 million by 2030.
  • The France market is expected to grow at a CAGR of 6.5% from 2024 to 2030.
  • In terms of segment, jet was the largest revenue generating type in 2023.
  • Mesh is the most lucrative type segment registering the fastest growth during the forecast period.


Nebulizer market data book summary

Market revenue in 2023USD 58.1 million
Market revenue in 2030USD 90.6 million
Growth rate6.5% (CAGR from 2023 to 2030)
Largest segmentJet
Fastest growing segmentMesh
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationJet, Mesh, Ultrasonic
Key market players worldwideOMRON Corp, GE HealthCare Technologies Inc Common Stock, Koninklijke Philips NV, Allied Healthcare Products Inc, DeVilbiss Healthcare, Briggs Healthcare Corp., Beurer, PARI Group, Philip Morris International Inc, Aerogen


Other key industry trends

  • In terms of revenue, France accounted for 5.0% of the global nebulizer market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany nebulizer market is projected to lead the regional market in terms of revenue in 2030.
  • France is the fastest growing regional market in Europe and is projected to reach USD 90.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Nebulizer Market Scope

Nebulizer Market Companies

Name Profile # Employees HQ Website

France nebulizer market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nebulizer market will help companies and investors design strategic landscapes.


Jet was the largest segment with a revenue share of 62.99% in 2023. Horizon Databook has segmented the France nebulizer market based on jet, mesh, ultrasonic covering the revenue growth of each sub-segment from 2018 to 2030.


According to a study conducted by the Asthma Research Centre, approximately 18 out of 10,000 people in France suffer from severe asthma. However, COPD is also one of the growing public health concerns in France. According to WHO, burden of COPD is likely to increase in the near future mostly due to constant exposure to risk factors and growth in geriatric population.

It is estimated to be the third largest cause of deaths in France by 2030. In addition, various studies and models suggest an increase in the incidence of COPD, from 84.5% in 2005 to 95.8% in 2025, in France. COPD is expected to be more prevalent in women than in men.

In addition, according to a French journal, cases of cystic fibrosis in France is expected to increase by 45.5% between 2010 and 2015, corresponding to an increase by 18.4% in children and an increase by 75.7% in adults.

Reasons to subscribe to France nebulizer market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of France nebulizer market databook

  • Our clientele includes a mix of nebulizer market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the France nebulizer market , including forecasts for subscribers. This country databook contains high-level insights into France nebulizer market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

France nebulizer market size, by type, 2018-2030 (US$M)

France Nebulizer Market Outlook Share, 2023 & 2030 (US$M)

France nebulizer market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more